John T.  Treace net worth and biography

John Treace Biography and Net Worth

John T. Treace has over 25 years of experience in medical device marketing, sales, and general management. Mr. Treace founded our company in January 2014 and has served as our Chief Executive Officer and a member of our board of directors since our inception. Mr. Treace is the former Senior Vice President of US Sales and Global Marketing for Wright Medical Group, Inc., a medical device company, acquired by Stryker Corporation (NYSE: SYK) in November 2020. During a 12-year tenure with Wright, Mr. Treace served in a number of senior management roles including Vice President, Biologics and Extremities and Senior Director of Biologics Marketing. Before that, Mr. Treace held positions at Xomed Surgical Products, Inc., including as Director of Marketing and as Senior Product Manager, and with TreBay Medical Corp as Advertising & Marketing Director.  Mr. Treace also served on the board of directors of ENTrigue Surgical, acquired by Arthrocare Corporation in July 2013. Mr. Treace holds a B.S. in Finance from Seattle University.

What is John T. Treace's net worth?

The estimated net worth of John T. Treace is at least $52.05 million as of September 16th, 2024. Mr. Treace owns 6,523,095 shares of Treace Medical Concepts stock worth more than $52,054,298 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Treace may own. Additionally, Mr. Treace receives a salary of $1,090,000.00 as CEO at Treace Medical Concepts. Learn More about John T. Treace's net worth.

How old is John T. Treace?

Mr. Treace is currently 52 years old. There are 6 older executives and no younger executives at Treace Medical Concepts. Learn More on John T. Treace's age.

What is John T. Treace's salary?

As the CEO of Treace Medical Concepts, Inc., Mr. Treace earns $1,090,000.00 per year. Learn More on John T. Treace's salary.

How do I contact John T. Treace?

The corporate mailing address for Mr. Treace and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]. Learn More on John T. Treace's contact information.

Has John T. Treace been buying or selling shares of Treace Medical Concepts?

John T. Treace has not been actively trading shares of Treace Medical Concepts during the last ninety days. Most recently, on Monday, September 16th, John T. Treace bought 50,000 shares of Treace Medical Concepts stock. The stock was acquired at an average cost of $5.31 per share, with a total value of $265,500.00. Following the completion of the transaction, the chief executive officer now directly owns 6,523,095 shares of the company's stock, valued at $34,637,634.45. Learn More on John T. Treace's trading history.

Who are Treace Medical Concepts' active insiders?

Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.

Are insiders buying or selling shares of Treace Medical Concepts?

During the last twelve months, Treace Medical Concepts insiders bought shares 12 times. They purchased a total of 812,902 shares worth more than $4,206,561.76. The most recent insider tranaction occured on September, 16th when CEO John T Treace bought 50,000 shares worth more than $265,500.00. Insiders at Treace Medical Concepts own 24.4% of the company. Learn More about insider trades at Treace Medical Concepts.

Information on this page was last updated on 9/16/2024.

John T. Treace Insider Trading History at Treace Medical Concepts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2024Buy50,000$5.31$265,500.006,523,095View SEC Filing Icon  
8/14/2024Buy85,000$6.00$510,000.006,473,095View SEC Filing Icon  
6/11/2024Buy45,000$5.88$264,600.006,388,095View SEC Filing Icon  
5/17/2024Buy100,000$5.56$556,000.006,343,095View SEC Filing Icon  
5/13/2024Buy150,000$4.56$684,000.006,093,095View SEC Filing Icon  
5/10/2024Buy150,000$4.58$687,000.005,943,095View SEC Filing Icon  
3/9/2023Sell2,075$24.41$50,650.755,539,380View SEC Filing Icon  
11/21/2022Buy15,000$21.83$327,450.005,541,455View SEC Filing Icon  
11/17/2022Buy10,000$21.67$216,700.005,526,455View SEC Filing Icon  
8/26/2022Buy21,491$20.95$450,236.455,506,455View SEC Filing Icon  
8/23/2022Buy28,000$18.72$524,160.005,484,455View SEC Filing Icon  
12/29/2021Sell3,075$17.01$52,305.75View SEC Filing Icon  
12/27/2021Sell17,165$17.44$299,357.60View SEC Filing Icon  
12/22/2021Sell41,710$16.29$679,455.90View SEC Filing Icon  
12/20/2021Sell22,911$15.75$360,848.25View SEC Filing Icon  
11/24/2021Sell56,000$17.84$999,040.00View SEC Filing Icon  
11/22/2021Sell53,000$18.35$972,550.00View SEC Filing Icon  
10/22/2021Sell58,089$20.74$1,204,765.86View SEC Filing Icon  
10/20/2021Sell30,827$24.94$768,825.38View SEC Filing Icon  
4/27/2021Sell5,253,805$17.00$89,314,685.0011,171,385View SEC Filing Icon  
See Full Table

John T. Treace Buying and Selling Activity at Treace Medical Concepts

This chart shows John T Treace's buying and selling at Treace Medical Concepts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Treace Medical Concepts Company Overview

Treace Medical Concepts logo
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Read More

Today's Range

Now: $7.98
Low: $7.59
High: $8.01

50 Day Range

MA: $5.82
Low: $4.66
High: $8.29

2 Week Range

Now: $7.98
Low: $3.92
High: $15.98

Volume

427,071 shs

Average Volume

787,974 shs

Market Capitalization

$497.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24